ArticleChemistry (Weinheim an der Bergstrasse, Germany)2026
An Achiral Tetradentate Cis-α-Coordinating NCCN Ligand Gives Rise to a Configurationally Stable Chiral-at-Iron Complex for Enantioselective Catalysis.
Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Imidazol-2-ylidene-Based NCCN Ligands for Chiral-at-Iron Catalysis.Organometallics · 2026Article
- An Achiral Tetradentate Cis-α-Coordinating NCCN Ligand Gives Rise to a Configurationally Stable Chiral-at-Iron Complex for Enantioselective Catalysis.Chemistry (Weinheim an der Bergstrasse, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Ligand design plays a crucial role in developing chiral transition metal complexes with enhanced or new catalytic properties. Here, we report our progress toward a new class of linear tetradentate NCCN ligands incorporating strongly σ-donating carbene moieties. The NCCN ligand coordinates to iron(II) in a cis-α topology, with two pyridine donors occupying the apical positions and two 1,2,3-triazolin-5-ylidene mesoionic carbene (MIC) donors in the equatorial plane. Two acetonitrile ligands complete the octahedral coordination sphere, and their lability provides the basis for the observed catalytic activity. Notably, the two strongly σ-donating MIC groups create a strong ligand field, which is critical for achieving configurational stability of the metal-centered stereogenicity. This design strategy thus enabled the first chiral-at-iron catalyst derived from an achiral tetradentate ligand, which was applied to catalytic and enantioselective C(sp
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.